Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Carocare Wellness vs Queen RX

Carocare Wellness
Graded #378

Lower grade

vs+8.199999999999996
Queen RX
Graded #192

Higher grade

The verdict

Queen RX takes it — 66.3/100 to 58.1/100.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +18
59
77
Dose & formulationCarocare Wellness +7
64
57
Clinical oversightEven
69
69
Labs & monitoringEven
53
53
FulfillmentQueen RX +15
60
75
Contract termsQueen RX +41
20
61
Carocare Wellness · left barQueen RX · right bar

The numbers

MetricCarocare WellnessQueen RX
WeighScore58.1/10066.3/100
GradeCC
Scorecard rank#378#192
Semaglutide$170/mo (compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$200/mo (compounded)Not disclosed
Coverage1 state45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Carocare Wellness

Graded #378 · C

Strengths

  • Real, named local clinic in Houston with hands-on provider support, in-person visits and Google-reviewed patient experiences
  • Low entry pricing — semaglutide from $170 and tirzepatide from $200 in month 1, with 3-month bundles ($500 / $600) that cut the effective monthly cost
  • Packages include ongoing provider support, supplies and delivery
  • Also offers IV hydration and NAD+ if you want broader wellness services in one place

Where it loses points

  • Houston/Texas only — no nationwide telehealth, so it is not an option outside the local area
  • Dose-escalating pricing climbs steeply (semaglutide reaches $330 by month 5; tirzepatide $425 by month 6)
  • Compounding pharmacy is not named, and there is no LegitScript or published clinical-oversight detail
  • Small single-location operation with no patient portal — booking and support run through Calendly and direct contact
  • Compounded semaglutide and tirzepatide only — no brand-name or oral options
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard